WuXi Biologics (Cayman) (2269.HK) Earnings Analysis
WuXi Biologics (Cayman) (2269.HK) next reports earnings on 2026-08-26, consensus EPS 0.52 HKD. Last quarter (2026-03-24) it missed with EPS 0.679 HKD vs 0.705 HKD est (-3.7%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 28.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2269.HK next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | 0.52 HKD |
| Revenue estimate | 13.22B |
2269.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | 0.679 HKD | 0.705 HKD | -3.7% | Miss |
| 2025-08-19 | 0.599 HKD | 0.4902 HKD | +22.2% | Beat |
| 2025-03-24 | 0.2397 HKD | 0.4688 HKD | -48.9% | Miss |
| 2024-08-21 | 0.3753 HKD | 0.4396 HKD | -14.6% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
2269.HK valuation and analyst view
| Trailing P/E | 28.46 |
|---|---|
| Trailing EPS | 1.164 HKD |
| Price / book | 3.02 |
| Dividend yield | 0.00% |
| Market cap | 160.94B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is WuXi Biologics (Cayman) (2269.HK)'s next earnings date?
WuXi Biologics (Cayman) is next scheduled to report on 2026-08-26, with a consensus EPS estimate of 0.52 HKD and revenue estimate of 13.22B.
Did 2269.HK beat earnings last quarter?
In its 2026-03-24 report, 2269.HK posted EPS of 0.679 HKD versus a 0.705 HKD estimate — a miss of 3.7%.
What is 2269.HK's earnings track record?
Over the last 4 reported quarters with consensus data, 2269.HK beat estimates 1 times (25%).
What is 2269.HK's current P/E ratio and EPS?
2269.HK trades at a trailing P/E of 28.46 on trailing EPS of 1.1637792892667886 HKD.
What do analysts rate 2269.HK?
2269.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.